Also, in-vivo administration of OxLys-SNAs significantly increased cytotoxic CD8 + T cells and decreased myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment relative to other groups (simple mixtures of oxidized lysates with CpG-1826 and Lys-SNAs). The gene discussed is CD8A; the disease is neoplasm.